4,560 video views


About ADCReview
Description: ADC Review / Journal of Antibody-Drug Conjugates (ISSN: 2327-0152) is an Open Access hybrid publication. The publication includes a Social Media (peer-to-peer) shell with a controlled but freely accessible Open Access peer review journal. The Journal aims to serve the needs of a diverse community of individuals involved in the field of antibody drug development, including academia, life sciences, pharma, (basic, translational and clinical) research and clinicians. ADC Review / Journal of Antibody-drug Conjugates provides peer reviewed publications under five broad headings: - Translational therapeutics - Technology - Manufacturing - Clinical studies - Clinical use and effectiveness The Journal is designed to appeal to and bring together the best research and medical minds from universities and commercial pharmaceutical manufacturers, along with specialized physicians/oncologists, regulatory/government authorities and representatives from payers and policy makers, enabling readers to find the most important information from one publication. The Journal gives sponsors access to a difficult-to-reach group of researchers. While being editorial independent, the publication can deliver sponsors the opportunity to deliver their corporate and product messages directly to the intended target audience.

Company: ADC Review / Journal of Antibody-drug Conjugates is published by InPress Media Group, LLC
Links
Channel Url:

Website:


Other Links:


Social Links: